Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

✍ Scribed by Paul Harmatz; Roberto Giugliani; Ida Schwartz; Nathalie Guffon; Elisa Leão Teles; M. Clara Sá Miranda; J. Edmond Wraith; Michael Beck; Laila Arash; Maurizio Scarpa; Zi-Fan Yu; Janet Wittes; Kenneth I. Berger; Mary S. Newman; Ann M. Lowe; Emil Kakkis; Stuart J. Swiedler

• Book ID: 116683770
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 276 KB
• Volume: 148
• Category: Article
• ISSN: 1097-6833
• DOI: 10.1016/j.jpeds.2005.12.014